Home/Filings/4/0001127602-23-024445
4//SEC Filing

Nicholson Nur 4

Accession 0001127602-23-024445

CIK 0001492422other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:03 PM ET

Size

10.7 KB

Accession

0001127602-23-024445

Insider Transaction Report

Form 4
Period: 2023-09-18
Nicholson Nur
Chief Technical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-18$29.76/sh+9,719$289,23773,634 total
  • Sale

    Common Stock

    2023-09-18$42.21/sh9,719$410,22463,915 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-09-189,719115,281 total
    Exercise: $29.76Exp: 2030-08-16Common Stock (9,719 underlying)
  • Sale

    Common Stock

    2023-09-18$46.15/sh10,631$490,58953,284 total
Footnotes (4)
  • [F1]This transaction was executed in multiple trades at prices ranging from $46.200 - $46.250. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $46.140 - $46.240. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This includes 412 shares from 04/30/2023 ESPP purchase.
  • [F4]This stock option was granted on August 17, 2020 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001827317

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:03 PM ET
Size
10.7 KB